武汉大学人民医院湖北省人民医院

院内导航

张旃 康复医学科
科主任，基地主任，主任医师，硕士生导师

A+ A-

导师介绍

姓名	张旃
出生年月	1974年9月
单位	武汉大学人民医院康复科
所属学科	临床医学-康复科
职务、职称及头衔	科主任，基地主任，主任医师，硕士生导师
E-mail	3092115953@qq.com
联系方式	027-88041911转83506，18062567610
研究方向	1.心肺康复 2.神经康复
个人简介	主要从事心肺康复、神经康复的诊治与科研工作，参与及主持多项国家自然科学基金和省卫生厅课题。发表论文20余篇。
学术任职与荣誉	中国康复学会运动康复专委会理事老年医学会康复专委会委员中德医学协会康复医学专委会委员武汉物理医学与康复学分会常务理事中国医学救援协会重症医学分会常务理事中国医学救援协会重症医学分会呼吸治疗学组副组长湖北省病理生理学会呼吸专业委员会呼吸康复联盟委员会联盟副主席
教育履历	2005/09-2011/07南方医科大学，附属南方医院呼吸内科学，博士1997/09-2000/07武汉大学，附属武汉大学人民医院呼吸内科学，硕士 1992/09-1997/07武汉大学，医学院临床医学专业，学士
工作履历	2022/03-至今，武汉大学，武汉大学人民医院康复科，主任医师 2020/06-2022.2，武汉大学，武汉大学人民医院呼吸与危重症医学科，主任医师 2012/08-2020.6，武汉大学，武汉大学人民医院呼吸与危重症医学科，副主任医师 2011/07-2012/07，广州医学院，第二附属医院呼吸与危重症医学科，副主任医师 2010/01-2011/01哈佛医学院Brigham医院内科实验室(Channing Lab)访问学者 2006/01-2011/06，广东省第二人民医院呼吸与危重症医学科，副主任医师 2002/08-2005/12，广东省第二人民医院心肺内科，主治医师
成果获奖	“脑卒中神经保护的相关分子机制及精准治疗” 2022年湖北省科技进步二等奖
代表性论著	1. Zhang Z#, Li X, Zhang W, Shi ZL, Zheng Z, Wang T. Clinical Features and Treatment of 2019-nCov Pneumonia Patients in Wuhan: Report of A Couple Cases. Virol Sin. 2020 Jun;35(3):330-336. doi: 10.1007/s12250-020-00203-8. Epub 2020 Feb 7. PMID: 32034637; PMCID: PMC7091133. 2. Nie S, Han S, Ouyang H, Zhang Z. Coronavirus Disease 2019-related dyspnea cases difficult to interpret using chest computed tomography. Respir Med. 2020 Jun;167:105951. doi: 10.1016/j.rmed.2020.105951. Epub 2020 Apr 6. PMID: 32421539; PMCID: PMC7195086. 3. Liu C, He P, Guo Y, Tian Q, Wang J, Wang G, Zhang Z, Li M. Taurine attenuates neuronal ferroptosis by regulating GABAB/AKT/GSK3β/β-catenin pathway after subarachnoid hemorrhage. Free Radic Biol Med. 2022 Nov 20;193(Pt 2):795-807. doi: 10.1016/j.freeradbiomed.2022.11.003. Epub 2022 Nov 17. Erratum in: Free Radic Biol Med. 2023 Jan;194:160-162. PMID: 36402441. 4. Tian Q, Guo Y, Feng S, Liu C, He P, Wang J, Han W, Yang C, Zhang Z, Li M*. Inhibition of CCR2 attenuates neuroinflammation and neuronal apoptosis after subarachnoid hemorrhage through the PI3K/Akt pathway. J Neuroinflammation. 2022 Dec 25;19(1):312. doi: 10.1186/s12974-022-02676-8. PMID: 36566220; PMCID: PMC9789920. 5. Gong P#, Zhang Z#, Zou Y, Tian Q, Han S, Xu Z, Liao J, Gao L, Chen Q, Li M. Tetramethylpyrazine attenuates blood-brain barrier disruption in ischemia/reperfusion injury through the JAK/STAT signaling pathway. Eur J Pharmacol. 2019 Jul 5;854:289-297. doi: 10.1016/j.ejphar.2019.04.028. Epub 2019 Apr 17. PMID: 31004602. 6. Gong P#, Zhang Z#, Zou C, Tian Q, Chen X, Hong M, Liu X, Chen Q, Xu Z, Li M, Wang J. Hippo/YAP signaling pathway mitigates blood-brain barrier disruption after cerebral ischemia/reperfusion injury. Behav Brain Res. 2019 Jan 1;356:8-17. doi: 10.1016/j.bbr.2018.08.003. Epub 2018 Aug 6.

Name	ZHAN ZHANG
Date of birth	Sep.1974
Department	Rehabilitation Department，Renmin Hospital,Wuhan University.
Title	Director, master tutor
Email	3092115953@qq.com
TEL	027-88041911-83506 or 18062567610
Research Direction	1. cardiopulmonary rehabilitation 2. neural rehabilitation
Personal Profile	She is mainly engaged in cardiopulmonary rehabilitation and neural rehabilitation,and has managed and participated in many item of the National Natural Science Foundation and items from the provincial science and Technology Department and the Provincial Health Department.There are more than 20 articles published in domestic and foreign journal.
Selected Publications	1. Zhang Z#, Li X, Zhang W, Shi ZL, Zheng Z, Wang T. Clinical Features and Treatment of 2019-nCov Pneumonia Patients in Wuhan: Report of A Couple Cases. Virol Sin. 2020 Jun;35(3):330-336. doi: 10.1007/s12250-020-00203-8. Epub 2020 Feb 7. PMID: 32034637; PMCID: PMC7091133. 2. Nie S, Han S, Ouyang H, Zhang Z. Coronavirus Disease 2019-related dyspnea cases difficult to interpret using chest computed tomography. Respir Med. 2020 Jun;167:105951. doi: 10.1016/j.rmed.2020.105951. Epub 2020 Apr 6. PMID: 32421539; PMCID: PMC7195086. 3. Liu C, He P, Guo Y, Tian Q, Wang J, Wang G, Zhang Z, Li M. Taurine attenuates neuronal ferroptosis by regulating GABAB/AKT/GSK3β/β-catenin pathway after subarachnoid hemorrhage. Free Radic Biol Med. 2022 Nov 20;193(Pt 2):795-807. doi: 10.1016/j.freeradbiomed.2022.11.003. Epub 2022 Nov 17. Erratum in: Free Radic Biol Med. 2023 Jan;194:160-162. PMID: 36402441. 4. Tian Q, Guo Y, Feng S, Liu C, He P, Wang J, Han W, Yang C, Zhang Z, Li M*. Inhibition of CCR2 attenuates neuroinflammation and neuronal apoptosis after subarachnoid hemorrhage through the PI3K/Akt pathway. J Neuroinflammation. 2022 Dec 25;19(1):312. doi: 10.1186/s12974-022-02676-8. PMID: 36566220; PMCID: PMC9789920. 5. Gong P#, Zhang Z#, Zou Y, Tian Q, Han S, Xu Z, Liao J, Gao L, Chen Q, Li M. Tetramethylpyrazine attenuates blood-brain barrier disruption in ischemia/reperfusion injury through the JAK/STAT signaling pathway. Eur J Pharmacol. 2019 Jul 5;854:289-297. doi: 10.1016/j.ejphar.2019.04.028. Epub 2019 Apr 17. PMID: 31004602. 6. Gong P#, Zhang Z#, Zou C, Tian Q, Chen X, Hong M, Liu X, Chen Q, Xu Z, Li M, Wang J. Hippo/YAP signaling pathway mitigates blood-brain barrier disruption after cerebral ischemia/reperfusion injury. Behav Brain Res. 2019 Jan 1;356:8-17. doi: 10.1016/j.bbr.2018.08.003. Epub 2018 Aug 6.